US Remote Patient Monitoring Market worth US$29.13 billion by 2030 with 12.8% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., March 20, 2025 /PRNewswire/ -- The global US Remote Patient Monitoring Market, valued at US$14.15 billion in 2024, is forecasted to grow at a robust CAGR of 12.8%, reaching US$29.13 billion by 2030. The growing number of elderly individuals and the increasing demand for cost-effective healthcare solutions are key drivers of the remote patient monitoring (RPM) market in the US. According to the Population Reference Bureau, US population aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, marking a 47% increase. During this period, the share of seniors in the total population is projected to rise from 17% to 23%. For example, US companies such as Boston Scientific Corporation, Abbott, and Dexcom enhance RPM through digital biomarkers and AI-driven analytics. Government initiatives, including Medicare reimbursement for RPM services and the CMS Hospital-at-Home program, further accelerate adoption.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77155492
Browse in-depth TOC on "Remote Patient Monitoring Market"
200 - Tables
50 - Figures
395 - Pages
By Based on component, the US remote patient monitoring market has been segmented into devices, software and services. In 2023, device segment is estimated to hold the largest share in the US remote patient monitoring market. Recent innovations in the US remote patient monitoring (RPM) market such as in March 2024, Dexcom (US) receives FDA clearance for Stelo a glucose biosensor. The device is connected to a smartphone for continuous glucose monitoring. Furthermore, the American Hospital Association supports the remote care delivery across state lines. These initiatives collectively aim to enhance patient care through improved access and technology integration in healthcare systems
By patients' segment, the fastest growth in the US remote patient monitoring market due to the rising patient awareness, increase in the prevalence of chronic diseases rises, and growing preference for home health care. The advancements in wearable technology and mobile health applications have made it easier for patients to engage with their health data actively. For instance, in August 2023, GE HealthCare (US) received 510(k) clearance from the US FDA for its Portrait Mobile wireless and wearable monitoring solution that provides personalized view of patient vitals. The US RPM market is expanding further due to the rising demand for affordable healthcare solutions, especially as the aging population becomes increasingly comfortable with technology.
By Based on indication, the US remote patient monitoring market has been segmented into cardiology, diabetes, oncology, neurology, sleep disorders, wellness improvement, respiratory disorders, mental health, and other indications. The cardiology segment holds the largest share in the US remote patient monitoring market due to the increase in the cardiovascular diseases, and advancements in products that provide real-time cardiac data. According to the American Heart Association, approximately 2,300 people die from cardiovascular diseases (CVDs) each day in the US alone and according to the WHO, every year, CVDs cause 17.9 million deaths worldwide. Further improvements, such as in June 2024, AliveCor, Inc. (US) announced FDA clearance for Kardia 12L ECG system that detect 35 cardiac determinations, including heart attacks, using a reduced lead set.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=77155492
Some of the prominent players in the US remote patient monitoring market includes GE HealthCare (US), Oracle (US), Boston Scientific Corporation (US), VitalConnect (US), Abbott (US), Optum, Inc (US), Blue Spark Technologies (US), Lightbeam (US) and others.
For more information, Inquire Now!
Related Reports:
Patient Monitoring Devices Market
Diagnostic Electrocardiograph Market
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
In addition, MarketsandMarkets SalesIQ enables sales teams to identify high-priority accounts and uncover hidden opportunities, helping them build more pipeline and win more deals with precision.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
Share this article